Dentsply Sirona (XRAY)
(Delayed Data from NSDQ)
$30.57 USD
+0.22 (0.72%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $30.63 +0.06 (0.20%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth C Momentum A VGM
Price, Consensus and EPS Surprise
XRAY 30.57 +0.22(0.72%)
Will XRAY be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for XRAY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for XRAY
Why Dentsply International (XRAY) is a Top Value Stock for the Long-Term
Why Dentsply International (XRAY) is a Top Value Stock for the Long-Term
XRAY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Dentsply International (XRAY) is a Strong Value Stock
Here's Why Dentsply International (XRAY) is a Strong Value Stock
Reasons to Retain DENTSPLY SIRONA (XRAY) in Your Portfolio Now
Other News for XRAY
Dentsply Sirona Inc. stock rises Friday, still underperforms market
Artisan Global Value Fund Q1 2024 Commentary
Dentsply Sirona Inc. stock underperforms Thursday when compared to competitors
Dentsply Sirona Inc. stock underperforms Wednesday when compared to competitors despite daily gains
Dentsply Sirona: I'm Buying The Pullback In This Medtech Leader